Diabetes - Continuous Subcutaneous Insulin Infusion

Practice Guidance Toolkit


Key Findings and Recommendations

Disclaimer

Children
MeasureEffect of CSII and Recommendations
Glycemic Control
Compared to multiple daily injections, continuous subcutaneous insulin infusion (CSII) use in children with type 1 diabetes may produce an improvement in glycemic control.
Quality of Life
Studies of children on CSII and their caregivers do not show consistent results relating to quality of life. Despite this, positive treatment satisfaction scores and reports of continued pump use by the majority of subjects after study
Continue Reading!

Login or signup to access PEN® content.

start free trial

Are you an existing member? Login here.

Last Updated: 2013-12-30